Mind Medicine (MindMed) Inc. (MNMD): Price and Financial Metrics

Mind Medicine (MindMed) Inc. (MNMD): $2.91

0.03 (+1.04%)

POWR Rating

Component Grades













Add MNMD to Watchlist
Sign Up

Industry: Biotech



in industry

MNMD Stock Price Chart Interactive Chart >

Price chart for MNMD

MNMD Price/Volume Stats

Current price $2.91 52-week high $19.95
Prev. close $2.88 52-week low $2.12
Day low $2.82 Volume 239,200
Day high $2.93 Avg. volume 530,770
50-day MA $3.45 Dividend yield N/A
200-day MA $5.78 Market Cap 110.76M

Mind Medicine (MindMed) Inc. (MNMD) Company Bio

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

MNMD Latest News Stream

Event/Time News Detail
Loading, please wait...

MNMD Latest Social Stream

Loading social stream, please wait...

View Full MNMD Social Stream

Latest MNMD News From Around the Web

Below are the latest news stories about MIND MEDICINE (MINDMED) INC that investors may wish to consider to help them evaluate MNMD as an investment opportunity.

MindMed Reports Full Year 2022 Financial Results and Business Highlights

NEW YORK, March 09, 2023--Mind Medicine (MindMed) Inc. today reported its financial results for the full-year ended December 31, 2022.

Yahoo | March 9, 2023

MindMed to Participate in March Investor Conferences

NEW YORK, February 28, 2023--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences:

Yahoo | February 28, 2023

Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific

By Exec Edge Editorial Staff Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York. The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines […]

Yahoo | February 16, 2023

The 7 Most Promising Psychedelic Stocks to Buy in February

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Muslim Farooque on InvestorPlace | February 5, 2023

Trippy Trading: Top Psychedelic Stocks For 2023

When psychedelics were first studied more than 50 years ago, researchers discovered that they were useful in assisting people in exploring a greater sense of self. After a half-century hiatus, scie...

Yahoo | January 17, 2023

Read More 'MNMD' Stories Here

MNMD Price Returns

1-mo -20.49%
3-mo N/A
6-mo -52.45%
1-year -83.56%
3-year N/A
5-year N/A
YTD 32.27%
2022 -89.37%
2021 -54.75%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8059 seconds.